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A Shocking Solution: Electroconvulsive Therapy and its Effects on 
Depression and Other Mental Illnesses 
Victoria Cook 
 
Abstract: Mental illness and its treatments continue to be demanding topics requiring the attention of the healthcare community. While 
pharmaceutical treatments increase in popularity, many people remain unaware of the non-pharmacological options available. One of the 
available unconventional treatment methods includes electroconvulsive shock therapy, a technique that utilizes bouts of electricity to 
stimulate anti-depressive behaviors. Although its methods have been disputed for a long time, electroconvulsive shock therapy is a long-
standing and effective treatment for depression. Electroconvulsive shock therapy has a dense history which has led to the stigmatization 
of it as a treatment, and it has credible downsides. Electroconvulsive shock therapy has been proven to work and its use can be promoted 
via further research on the topic. 
epression is the leading cause of disability worldwide and is 
recognized as one of the major contributors to the global 
burden of disease.1 Historically, society casted the treatment of 
mental illnesses in a negative light. However, with an increase in 
the recognition of mental illness as a true obstacle to wellness 
the stigma surrounding mental illness begins to slowly fade. The 
focus has shifted away from acknowledgement and towards 
treatment. Prescription drugs are commonly viewed as the sole 
agent in combating mental illness. However, there are many 
other novel therapies posing as potential treatments. One of the 
most notable therapeutic options is electroconvulsive therapy 
(ECT), which essentially shocks a patient into good health. While 
shocking a person into an epileptic episode may appear barbaric 
and better suited for a low-budget horror film, there has been a 
surprising number of successful cases where these convulsions 
alleviate the symptoms of mental illness, particularly 
depression.2 Despite the success of ECT, several less desirable 
effects merit hesitation.3 Perhaps even more intriguing than the 
effects of ECT, are the mechanisms by which electricity helps 
relieve depression. Successful treatments certainly warrant 
curiosity, but the treatment’s scarcity in healthcare is largely 
unjustified and based on stigma rather than evidence-based 
results. Overall, ECT deserves more attention both in clinical and 
research settings within the medical field.  
 
HISTORY 
 The mistreatment of the mentally ill reached its peak in 
the 19th century with a surge in the number of mental asylums. 
Fear of mental illness was spurred on by the growth of popula-
tions caused by the Industrial Age and was transformed into the 
imprisonment of those who suffered from mental illnesses.4 
Luckily, scientists and other specialists searched for innovative 
solutions to the conditions now known as schizophrenia and de-
pression. In trials ran by Manfred Sankel in 1927, insulin was 
used to treat schizophrenia by inducing seizure activity in the 
patient. Unfortunately, the success did not last, and most 
patients returned to their pre-treatment state.5 In 1934, me-
trazol, a drug that caused similar convulsive episodes, was intro-
duced.5 These metrazol-induced seizures eventually became the 
main inspiration behind the first ECT techniques, introduced by 
Ugo Cerlatti in 1938.2 The trials leading up to Cerlatti’s estab-
lished convulsions of the body could improve a patient’s mental 
state, but his new techniques allowed ECT to surpass its prede-
cessors as a suitable treatment.5 Metrazol failed to gain traction 
as a treatment for mental disease due to the lack of instantane-
ous loss of consciousness which was achieved with Cerlatti’s ECT. 
Within a few successful treatments, Cerlatti’s ECT had proved to 
be a safer and more popular way to improve mental illness than 
metrazol.5 Within months, Cerlatti and his team recognized ECT’s 
ability to alleviate symptoms of depression better than 
schizophrenia, its targeted illness.2 Soon, ECT was on track to 
become a promising medical treatment for depression. 
 
THE FACTS 
 Today, ECT is most often used in patients who suffer 
from major depression with resistance to pharmaceutical drugs. 
Patients prescribed ECT for depression may also come to the 
clinic with symptoms of catatonia, a state of immobility; mania, 
a state of abnormally heightened mood; or lethargy. ECT, 
introduced to battle depression in the 1930s, is still considered 
the most successful treatment for severe depression with 
efficacy rates of 80-90%.6,7 Professionals regard the widespread 
evidence supporting ECT treatment as among the strongest for 
any medical treatment, due to the large amount of data 
collected since the first ECT treatment in the 19th century.7 ECT 
is also highly recommended for patients who have recently 
expressed suicidal thoughts and behavior because it is proven 
to work quicker than antidepressants.6,8   
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WHY AND HOW DOES IT WORK? 
Although ECT is not a new development in the 
treatment of mental illness, the mechanisms behind ECT are still 
unclear. Several theories continue to develop as research 
advances. Discovering the mechanisms of ECT dates to Sigmund 
Freud, the first to report a connection between psychological 
conditions and biological processes in the brain and nervous 
system. This contrasted with the psychological theory of that 
time in which mental illness was linked to personality and early 
childhood experiences.5 Many doctors assumed a defective 
nervous system led to mental illness, which pushed them to 
research treatments that included electrically stimulating patient 
brains.4 Another key discovery during the early days of ECT was 
the “biological antagonism” between epilepsy and mental 
disease, specifically schizophrenia.5 Because those suffering 
from seizures did not typically suffer from mental disease, 
researchers like Cerlatti induced seizures in patients to cure their 
mental disease.2  
To understand how ECT works, researchers focused on 
changes in the brain after ECT sessions. Current research 
indicates an increase in both neurogenesis and cell proliferation 
in the brain after electroconvulsive seizures.6 Neurogenesis is the 
production of new neurons. This process slows under stress and 
drug abuse, which are commonly seen in conjunction with 
depression.9 While neurogenesis appears to counteract the 
effects of stress, recent studies have also indicated increases in 
neurogenesis after brain trauma.10 Cell proliferation, or growth, 
occurs alongside neurogenesis in the same portion of the brain 
and counteracts depression-like symptoms. Unlike 
neurogenesis, cell growth drops dramatically after about two 
weeks post-ECT, aligning with the patient’s relapse back to his 
or her depressed state. Due to the coincidental timing of 
patients halting cell growth and returning to their depressed 
state, researchers propose the effectiveness of ECT in patients 
with depression and its lack of long-lasting effects are due to the 
seizure’s stimulation of cell proliferation.6 
Another theory for the explanation of how ECT works 
notes how ECT increases levels of glutamate and GABA, two 
chemicals essential for brain function.9 Low levels of glutamate 
and GABA are typically found in individuals with depression. 
Therefore, ECT appears to alleviate symptoms of depression by 
affecting the activity of these two chemicals. Similar to 
neurogenesis and cell proliferation, increases in glutamate and 
GABA levels are linked to head trauma. Most people would find 
the correlation between trauma and ECT alarming, but the 
processes may serve as recuperative functions for the brain.9 The 
lack of an adopted mechanism of action for ECT necessitates 
further research.  
 
WHY THE BAD REPUTATION? 
With widespread evidence supporting the effectiveness 
of ECT in treating mental diseases, a person is left to wonder why 
ECT is a less popular treatment option than the drugs found on 
pharmacy shelves. Several reasons exist for the incongruity. To 
start, ECT’s treatment method is slightly frightening and 
exacerbated by negative stereotypes portrayed in the media.6 To 
make matters worse, the history of ECT did not proceed in a 
righteous manner. Psychiatric wards arrived with the growth of 
cities in the 1900s and were known to sedate unruly patients 
with a form of ECT. Then in the 1970s, a new wave of protests 
against the institutionalization of mentally ill patients portrayed 
both the institutions and ECT treatments in a negative shadow.5 
While abuse was present in these institutions, the unethical and 
inappropriate use of ECT treatment should not have dismissed 
its effectiveness. 
Conflicting reports about ECT’s effectiveness have 
surfaced over the years, but these can be mostly attributed to its 
inappropriate application. ECT was used for a wide range of 
mental disorders, even when the patients did not improve.6 The 
overuse of ECT made the treatment appear less effective, further 
discrediting it.  Using electricity to cure a disease may not appear 
logical or safe, but with the correct application and regulation, it 
can be effective.  
 
CREDIBLE DOWNSIDES 
Similar to prescription drugs used to treat mental 
illnesses, ECT has notable side effects. One of the major side 
effects, which has produced the most concern from medical 
professionals and patients, is the potential for memory loss. In 
every ECT case, the patient loses consciousness as soon as the 
first shock is administered.6 Then, the patient wakes up after the 
treatment with slight confusion, a headache, and little 
recollection of the course of the treatment.8 While lack of 
memory of the actual treatment is an attraction of ECT for many 
patients,2 memory loss can extend as far as six months before 
the treatment and two months after the treatment.8 However, 
there are techniques to reduce the negative effect on memory. 
If the procedure is performed with electrodes placed on only one 
side of the skull rather than on both sides, adverse effects on 
memory may be prevented.3 Any patient considering ECT should 
reflect on the potential for memory loss, but also acknowledge 
the potential side effects in other treatment options, like 
prescribed antidepressants.   
Unlike memory loss, which has proven to be a 
legitimate concern, other adverse effects of ECT have largely 
been reduced with proper technique and regulation. In the early 
days of ECT treatment, fractures and dislocations did occur 
infrequently,2 but these risks have been “virtually eliminated” 
since the 1980s. Death is another possibility but the chances of 
death occurring are similar to barbiturate anesthesia use, which 
is a common technique used within medical practices.8 
Another common critique of ECT is the high rate of 
relapse of patients back to their original state. ECT is not a cure. 
Therefore, when treatments stop, the positive effects typically 
stop as well. A recent study showed 84% of patients who did not 
receive any further treatment in the six months after their last 
ECT session relapsed into their previous state.  ECT is not viewed 
as a long-term treatment and the patient is usually given 
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antidepressants to prevent relapse, a combination that has 
proven to be successful. In fact, the same study mentioned 
earlier revealed only 39% of patients relapsed when the ECT 
treatment was followed by nortriptyline and lithium. While long-
term ECT, or continuation ECT, is another option, the effects of 
the extended treatment plan require more extensive research.11 
In comparison, medications used safely and frequently for 
extended periods of time also only alleviate symptoms 
temporarily.12 Most patients who receive ECT or conventional 
pharmaceutical treatment for a mental disorder are susceptible 
to relapse. 
 
CONCLUDING REMARKS 
 Despite the downsides of ECT and a need for more re-
search, this treatment method can be an incredibly useful tool in 
the battle against mental diseases. Although society has largely 
rejected its usage, ECT produces significant beneficial effects in 
those suffering from depression. In fact, a recent study asked the 
parents of teenagers who had undergone ECT about their expe-
rience and every parent responded positively. Additionally, none 
of the parents thought ECT was worse than other medications, a 
stance that opposes popular opinion.13 Unfortunately, many 
health centers do not have a policy for safe ECT practice, thus 
limiting patient access to ECT.6 As depression and other mental 
diseases gain attention and become less stigmatized, so must 
their treatments. No matter how uncommon, ECT is a viable 
treatment option in the healthcare world’s repertoire of tools to 
combat mental illnesses like depression. 
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